admin – Page 3906 – Get News Story

Chevron EOI: Workforce Reductions Emerge Following Headquarters Relocation to Houston

Chevron to Cut 15-20% of Workforce Amid HQ Move to Houston, Aiming $3B Savings by 2026. Layoffs Follow Voluntary Buyouts, Raising Concerns Over Refinery Closures & CA Gas Prices.

Chevron Corporation has announced plans to reduce its global workforce by an estimated 15% to 20%, aligning with an initiative to streamline operations and reduce expenditures by $3 billion by 2026. This decision follows Chevron’s headquarters transition from San Ramon, California, to Houston, Texas, a move aimed at fostering closer collaboration with industry leaders.

According to an internal memo, voluntary buyout options were extended to employees in April and May, with final layoffs scheduled to conclude by June. Chief Executive Officer Mike Wirth and Vice Chairman Mark Nelson guided the relocation earlier this year, emphasizing strategic advantages in the Houston market. Chevron reported a workforce of 45,600 employees as of December 2023 and indicated that positions tied to California’s refinery and technical operations will remain intact.

Recent developments suggest that Chevron has considered closing certain California refinery operations. Such action could notably affect gasoline prices in the region, given that the company’s refineries are responsible for producing approximately one-third of California’s gasoline. Any significant curtailment of refining capacity may pose challenges for both employees and consumers in the state.

The headquarters shift concludes a 145-year era in the Bay Area, where Chevron operated initially in San Francisco before relocating to San Ramon in 2001. The earlier move was partially influenced by proximity requirements for the Richmond refinery and concerns regarding San Francisco’s business tax policies. More recently, Chevron has expressed dissatisfaction with California’s regulatory framework, particularly in the realm of climate legislation. The corporation is currently embroiled in litigation with the state concerning its environmental impact, with Wirth voicing support for a global policy approach as opposed to what he terms “piecemeal litigation.”

Investor sentiment remains cautious, as reflected by a 1.6% dip in Chevron’s stock price following the announcement. Industry observers note that ongoing workforce restructuring and operational realignments have introduced a level of uncertainty into the company’s near-term outlook.

Burgeoning interest has emerged among professionals affected by these workforce changes in specialized retirement planning guidance. Wealth Enhancement offers a range of services that may assist Chevron personnel in examining pension options, 401(k) strategies, LTIPS, EOI and overall retirement benefits. Additional insights and resources are accessible at:

Click here for Complimentary Chevron Lunch and Dinner Events

Click here to read an artcle on the 5 Most Common Mistakes When Leaving Chevron

Click here to watch our video on the Chevron EOI

Source:

Vaziri, Aidin. “Chevron to Lay Off Thousands after Relocating Headquarters from Bay Area.” San Francisco Chronicle, 12 Feb. 2025, www.sfchronicle.com/bayarea/article/chevron-layoffs-20163221.php.

Disclaimer: Advisory services offered through Wealth Enhancement Advisory Services, LLC, a registered investment advisor and affiliate of Wealth Enhancement Group®. Trust services offered through Wealth Enhancement Trust Services, LLC, a trust company chartered under South Dakota law.

Check the background of investment professionals associated with this site on the Investment Advisor Public Disclosure website.

This site is published for residents of the United States only. Investment Advisor Representatives of Wealth Enhancement Advisory Services may only conduct business with residents of the states and jurisdictions in which they are properly registered. All information herein has been prepared solely for information purposes, and it is not an offer to buy or sell, or a solicitation of an offer to buy or sell any security.

Check the background of this investment professional on FINRA’s BrokerCheck.

The Retirement Group/Wealth Enhancement Group are not affiliated with Chevron.

Media Contact
Company Name: Wealth Enhancement
Contact Person: J McCaffrey
Email: Send Email
City: San Diego
State: California
Country: United States
Website: https://www.wealthenhancement.com/s/

Barrick supports UNESCO World Engineering Day 2025 campaign

Barrick, as a leader in the mining sector, has been selected as an official partner for UNESCO World Engineering Day for Sustainable Development (WED) 2025, which was launched at UNESCO Headquarters in Paris on 4 March 2025.

London, UK – Mar 7, 2025 – An International Day proclaimed by UNESCO General Conference and open to everyone, WED is jointly operated by UNESCO and the World Federation for Engineering Organisations (WFEO), which spans some 100 countries and represents more than 30 million engineers.

The launch in Paris marks the start of a year-long campaign of events, films and related articles and news, highlighting the achievements of engineers and engineering around the world, and promoting engineering as a career.

Produced by the SJH Group – the official media partner and broadcaster for WED – all campaign content, which includes a multimedia hub dedicated to Barrick, is hosted on the WED website at www.worldengineeringday.net.

As an official partner, Barrick’s insights and expertise will form an integral part of the 12-month campaign, which provides a springboard for governments, UN-associated organisations, policymakers, educators and leaders in the public and private sectors to raise awareness of the importance of engineering.

The WED campaign has an estimated global reach of more than 100 million individuals, and this year’s theme of “Shaping our sustainable future through engineering” focuses on the essential role that engineering has to play in achieving the UN’s 17 Sustainable Development Goals (SDGs).

“Barrick has long been championing its differentiated holistic approach to sustainability management,” says Juana Barcelo, President of Barrick Pueblo Viejo. “We are excited to be a partner for World Engineering Day 2025 and to demonstrate our work contributing to the UN’s SDGs.”

Addressing the significance of WED, Mustafa Shehu, President of the WFEO, says: “World Engineering Day 2025 is all about putting engineering in the global spotlight, showing how engineers are leading the way in the effort to meet the UN’s Sustainable Development Goal targets, and inspiring the next generation to find out more about what a career in engineering has to offer.”

Jacques de Mereuil, Executive Director of the WFEO, says: “We’re thrilled to be involved in launching this important international celebration and campaign at UNESCO’s global headquarters in Paris, and delighted to have Barrick involved, as an authority in mining.”

To view Barrick’s WED content, go to https://worldengineeringday.net/partner-stories/barrick/.

Notes to editor:

The WED 2025 launch, campaign and related content are live on www.worldengineeringday.net.

For further information about WED 2025 please email publishing@stjamess.org.

For further information about Barrick, please email barrick@dpapr.com, or pvdccommunications@barrick.com

Media Contact
Company Name: WED
Contact Person: Media Relations
Email: Send Email
Country: United Kingdom
Website: www.worldengineeringday.net

Chronic Myeloid Leukemia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Terns Pharma, Ascentage Pharma, Novartis, M.D. Anderson Cancer Center, Kartos Therapeutics

The Key Chronic Myeloid Leukemia Companies in the market include – Enliven Therapeutics, Terns Pharmaceuticals, Ascentage Pharma, Novartis, M.D. Anderson Cancer Center, Kartos Therapeutics, Groupe Francophone des Myelodysplasies, University of Jena, Takeda, Il-Yang Pharm. Co., Ltd., Shenzhen TargetRx, Inc., Bristol-Myers Squibb, Astex Pharmaceuticals, Inc., and others.

DelveInsight’s “Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Myeloid Leukemia, historical and forecasted epidemiology as well as the Chronic Myeloid Leukemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Chronic Myeloid Leukemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Myeloid Leukemia Market Forecast

Some of the key facts of the Chronic Myeloid Leukemia Market Report:

The Chronic Myeloid Leukemia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
In February 2025, Cipla has obtained final approval from the US FDA for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia (CML). The product is anticipated to be launched in the US during FY2025-26.
In November 2024, Marks Shorla Oncology has announced FDA approval for imatinib (Imkeldi), the first oral liquid tyrosine kinase inhibitor (TKI) authorized for treating multiple cancers, including gastrointestinal stromal tumors (GIST), myelodysplastic syndromes (MDS), myeloproliferative disease (MPD), chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
In November 2024, The U.S. Food and Drug Administration (FDA) has approved a reformulated version of nilotinib (Danziten) for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in the chronic phase. The approval also covers adult patients in the chronic or acute phase of CML who have shown resistance or intolerance to previous treatments, including imatinib.
In October 2024, Novartis has obtained accelerated approval from the U.S. Food and Drug Administration (FDA) for Scemblix (asciminib) for the treatment of adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP).
In January 2024, Terns Pharmaceuticals expected significant proof-of-concept results for TERN-701 (for Chronic Myeloid Leukemia) by the latter half of 2024.
In January 2024, Novartis reported favorable outcomes from the primary analysis of ASC4FIRST, a critical Phase III trial that compared SCEMBLIX against the preferred tyrosine kinase inhibitor (TKI) treatment chosen by investigators. This study focused on newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
According to projections by the American Cancer Society, around 9,280 individuals in the United States are expected to be diagnosed with CML in 2024, including 5,330 cases in men and 3,950 cases in women.
According to the NICE UK, CML has an annual incidence of 4.2 cases per 100,000 individuals. Additionally, CML accounts for only 5% of childhood leukemia cases. Moreover, it is noted that 85-90% of patients are diagnosed during the chronic phase of the disease.
In 2022, based on SEER data, it is projected that there will be approximately 8,860 new cases of CML in the United States.
Key Chronic Myeloid Leukemia Companies: Enliven Therapeutics, Terns Pharmaceuticals, Ascentage Pharma, Novartis, M.D. Anderson Cancer Center, Kartos Therapeutics, Groupe Francophone des Myelodysplasies, University of Jena, Takeda, Il-Yang Pharm. Co., Ltd., Shenzhen TargetRx, Inc., Bristol-Myers Squibb, Astex Pharmaceuticals, Inc., and others
Key Chronic Myeloid Leukemia Therapies: ELVN-001, TERN-701, HQP1351, ABL001, Asciminib, KRT-232, Venetoclax, Imatinib, Ponatinib, Radotinib, TGRX-678, Dasatinib, Azacitidine, and others
The Chronic Myeloid Leukemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Myeloid Leukemia pipeline products will significantly revolutionize the Chronic Myeloid Leukemia market dynamics.

Chronic Myeloid Leukemia Overview

Chronic Myeloid Leukemia (CML) is a type of cancer that begins in the blood-forming cells of the bone marrow. It is characterized by the uncontrolled growth of immature myeloid cells, which are a type of white blood cells. In CML, there is a genetic abnormality called the Philadelphia chromosome, which results from a translocation between chromosomes 9 and 22. This translocation leads to the formation of a fusion gene called BCR-ABL1, which produces a protein that promotes the excessive growth of myeloid cells.

Get a Free sample for the Chronic Myeloid Leukemia Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/chronic-myeloid-leukemia-market

Chronic Myeloid Leukemia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Chronic Myeloid Leukemia Epidemiology Segmentation:

The Chronic Myeloid Leukemia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Chronic Myeloid Leukemia
Prevalent Cases of Chronic Myeloid Leukemia by severity
Gender-specific Prevalence of Chronic Myeloid Leukemia
Diagnosed Cases of Episodic and Chronic Chronic Myeloid Leukemia

Download the report to understand which factors are driving Chronic Myeloid Leukemia epidemiology trends @ Chronic Myeloid Leukemia Epidemiology Forecast

Chronic Myeloid Leukemia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Myeloid Leukemia market or expected to get launched during the study period. The analysis covers Chronic Myeloid Leukemia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Chronic Myeloid Leukemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Chronic Myeloid Leukemia Therapies and Key Companies

ELVN-001: Enliven Therapeutics
TERN-701: Terns Pharmaceuticals
HQP1351: Ascentage Pharma
ABL001: Novartis
Asciminib: M.D. Anderson Cancer Center
KRT-232: Kartos Therapeutics
Venetoclax: Groupe Francophone des Myelodysplasies
Imatinib: University of Jena
Ponatinib: Takeda
Radotinib: Il-Yang Pharm. Co., Ltd.
TGRX-678: Shenzhen TargetRx, Inc.
Dasatinib: Bristol-Myers Squibb
Azacitidine: Astex Pharmaceuticals, Inc.

Discover more about therapies set to grab major Chronic Myeloid Leukemia market share @ Chronic Myeloid Leukemia Treatment Landscape

Chronic Myeloid Leukemia Market Strengths

Premium-price agents with superior efficacy such as immunotherapies and kinase inhibitors are expected to dominate the Chronic Myeloid Leukemia market.
Novel treatments like SCEMBLIX (asciminib) demonstrate specific targeting of the ABL myristoyl pocket, leading to improved safety and tolerability compared to current standard care.

Chronic Myeloid Leukemia Market Opportunities

Currently limited treatment options available for relapsed and refractory cases in Chronic Myeloid Leukemia.
Participation in and support for clinical trials provide opportunities to evaluate novel therapies, contributing to advancements in Chronic Myeloid Leukemia management.

Scope of the Chronic Myeloid Leukemia Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Chronic Myeloid Leukemia Companies: ELVN-001, TERN-701, HQP1351, ABL001, Asciminib, KRT-232, Venetoclax, Imatinib, Ponatinib, Radotinib, TGRX-678, Dasatinib, Azacitidine, and others
Key Chronic Myeloid Leukemia Therapies: ELVN-001, TERN-701, HQP1351, ABL001, Asciminib, KRT-232, Venetoclax, Imatinib, Ponatinib, Radotinib, TGRX-678, Dasatinib, Azacitidine, and others
Chronic Myeloid Leukemia Therapeutic Assessment: Chronic Myeloid Leukemia current marketed and Chronic Myeloid Leukemia emerging therapies
Chronic Myeloid Leukemia Market Dynamics: Chronic Myeloid Leukemia market drivers and Chronic Myeloid Leukemia market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Chronic Myeloid Leukemia Unmet Needs, KOL’s views, Analyst’s views, Chronic Myeloid Leukemia Market Access and Reimbursement

To know more about Chronic Myeloid Leukemia companies working in the treatment market, visit @ Chronic Myeloid Leukemia Clinical Trials and Therapeutic Assessment

Table of Contents

1. Chronic Myeloid Leukemia Market Report Introduction

2. Executive Summary for Chronic Myeloid Leukemia

3. SWOT analysis of Chronic Myeloid Leukemia

4. Chronic Myeloid Leukemia Patient Share (%) Overview at a Glance

5. Chronic Myeloid Leukemia Market Overview at a Glance

6. Chronic Myeloid Leukemia Disease Background and Overview

7. Chronic Myeloid Leukemia Epidemiology and Patient Population

8. Country-Specific Patient Population of Chronic Myeloid Leukemia

9. Chronic Myeloid Leukemia Current Treatment and Medical Practices

10. Chronic Myeloid Leukemia Unmet Needs

11. Chronic Myeloid Leukemia Emerging Therapies

12. Chronic Myeloid Leukemia Market Outlook

13. Country-Wise Chronic Myeloid Leukemia Market Analysis (2019–2032)

14. Chronic Myeloid Leukemia Market Access and Reimbursement of Therapies

15. Chronic Myeloid Leukemia Market Drivers

16. Chronic Myeloid Leukemia Market Barriers

17. Chronic Myeloid Leukemia Appendix

18. Chronic Myeloid Leukemia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Myeloid Leukemia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Terns Pharma, Ascentage Pharma, Novartis, M.D. Anderson Cancer Center, Kartos Therapeutics

Leading Portland Dentist Michael P. Naughton, DMD, Unveils Magnolia Dental

Dr. Naughton is sharing the official new name of his renowned dental office, which provides premier dental services for the Portland, Oregon, region.

PORTLAND, OREGON – March 7th, 2025 – Michael P. Naughton, DMD, is excited to announce the official new name of his dental office. New and existing clients alike are now being greeted by Magnolia Dental, which offers the same office, staff, and exceptional level of dental services that patients have come to know and love.

As Dr. Naughton continues his highly successful career in dental health, he has rebranded his Portland, Oregon, dental office. The new name – Magnolia Dental – signifies renewal and a bright future on the horizon as Dr. Naughton remains the first choice for many when it comes to local dentists.

Dr. Naughton graduated from OHSU School of Dentistry and then served in the U.S. Navy as a general dentist at Coronado Naval Air Station in California; at Holy Loch Naval Base in Scotland; and then completed his tour in Norfolk, Virginia. Afterwards, he moved back home to Portland Oregon and started his private practice. When he’s not serving patients in his dental office, Dr. Naughton can be found donating his time and skills to volunteer programs, local business groups, community sports teams, and more. He is proud of the time spent volunteering for pediatric dental patients at Crestin Clinic and for low income senior citizens at Senior Smile. He is an active member of the American Dental Association, the Academy of General Dentistry, the Oregon Dental Association, and the Central East Portland Rotary Club and participates in numerous study and research clubs.

Dr. Naughton is a well-known dentist in the Portland area, and through his private practice, he has served the region with an exceptional level of care for decades. At Magnolia Dental, new and existing patients alike are greeted with the height of professionalism and care. With a staff that is courteous and knowledgeable, Magnolia Dental provides world-class dental solutions that work with many insurance plans. Payment plans are also available.

Dr. Naughton provides general dentistry designed to promote and protect dental health. Fillings, bondings, sealants, x-rays, and gum treatments are just a few services that fall beneath the umbrella of dental health services offered at Magnolia Dental. Cosmetic dentistry including whitening and veneers is also available, as well as advanced services including root canals, implants, bridges, crowns, dentures, and TMJ treatments.

Magnolia Dental is pleased to welcome its existing patients back with its new name, and new patients are also being accepted at this time. Learn more now by visiting www.magnoliadentalpdx.com.

ABOUT MAGNOLIA DENTAL

Michael P. Naughton, DMD, and the team at Magnolia Dental offer premier dental health, cosmetic dentistry, and advanced dental solutions in Portland, Oregon.

Media Contact
Company Name: Magnolia Dental
Contact Person: Michael Naughton
Email: Send Email
Phone: (503) 253-7814
Address:9 NE 120th Ave
City: Portland
State: OR 97220
Country: United States
Website: https://magnoliadentalpdx.com/

Secret Africa: The Luxury Safari Company That Is Wowing Their Clients With Their Unique Local Knowledge

“Guests watching a leopard on an African safari.”

Secret Africa transforms luxury safaris by combining extensive local knowledge with personalized, high-end experiences in South Africa, Tanzania, Namibia, and Botswana. Unlike traditional tours, they provide unique access to hidden gems, personalize each itinerary, and prioritise sustainable tourism that benefits local communities. Whether it’s exclusive bush dinners, hot-air balloon safaris, or expert-guided animal encounters, Secret Africa guarantees an amazing voyage into the heart of Africa.

When it comes to luxury safaris in Africa, Secret Africa stands out from the crowd. This unique company not only offers lavish experiences but also brings a wealth of local knowledge to the table. Their deep ties to the continent allow them to craft unforgettable adventures that truly connect travelers with the heart of Africa. Let’s dive into what makes Secret Africa a top choice for those looking to explore this magnificent region.

Key Takeaways

Secret Africa provides personalized luxury safari experiences tailored to individual preferences.
Their local expertise ensures exclusive access to hidden gems often missed by other tour operators.
Sustainability and ethical tourism practices are central to their operations, promoting responsible travel.
Clients rave about the unforgettable memories created during their safaris, highlighting unique wildlife encounters.
Destinations offered include South Africa, Tanzania, Namibia, and Botswana, each with its own unique offerings.

Introduction to Secret Africa

So, you’re thinking about an African safari? Forget the usual tourist traps. Secret Africa is changing the game. They’re not just another tour company; they’re crafting unforgettable experiences based on real, in-depth knowledge of the continent.

Secret Africa specializes in creating personalized, luxurious safaris that go beyond the typical wildlife spotting. They focus on connecting you with the land and its people in a meaningful way. Think of it as adventure, but with a touch of class and a whole lot of authenticity.

Here’s what sets them apart:

Deep local connections that open doors to exclusive experiences.
A commitment to sustainable and ethical tourism practices.
Tailored itineraries designed around your specific interests and desires.

Basically, if you’re looking for a safari that’s more than just a vacation, Secret Africa might be your answer. They can help you plan your first safari in Africa and make it a memorable one.

What Makes Secret Africa Different?

Okay, so what really sets Secret Africa apart from all the other luxury safari companies out there? It’s not just about fancy lodges and spotting lions (though they definitely deliver on that!). It’s about a few key things that, when you put them all together, create a totally unique experience. I mean, anyone can book you a room, but Secret Africa goes way beyond that.

Unparalleled Local Knowledge

It’s one thing to read about Africa, it’s another to know Africa. Secret Africa’s team is made up of people who have lived and breathed the continent their whole lives. They aren’t just reading from a script; they’re sharing their own stories, their own experiences, and their own deep understanding of the land, the wildlife, and the cultures. It’s like having a friend who knows all the best kept secrets, and is willing to share them with you. This translates into:

Knowing the best times to visit specific locations for optimal wildlife viewing.
Having connections with local communities, leading to authentic cultural experiences.
Being able to adapt itineraries on the fly based on real-time information and conditions.

Luxury Tailored Experiences

Forget cookie-cutter tours. Secret Africa is all about crafting experiences that are as unique as you are. They take the time to really listen to what you want, what you’re interested in, and what your dreams are for your African adventure. Then, they use their knowledge and resources to create a safari that’s perfectly tailored to you. This could mean:

Arranging for private bush dinners under the stars.
Organizing hot air balloon rides over the savanna at sunrise.
Securing exclusive access to remote and untouched wilderness areas.
Offering specialized photography safaris with expert guides.

The Secret Africa Safari Experience

Secret Africa isn’t just about seeing the African safaris; it’s about truly experiencing them. We aim to go beyond the typical tourist trail, offering something deeper and more meaningful. It’s about connecting with the land, the wildlife, and the local communities in a way that leaves you changed.

Exclusive Access to Hidden Gems

Forget crowded viewpoints and predictable routes. We specialize in taking you to places others simply don’t know about. Think secluded watering holes teeming with wildlife, ancient rock art sites hidden in the bush, and private bush camps where you can fall asleep to the sounds of the African night. We achieve this through:

Long-standing relationships with local guides and communities.
Careful research and exploration to uncover new and exciting locations.
A commitment to responsible tourism that respects the environment and local cultures.

Sustainable and Ethical Tourism

We believe that African safaris should benefit both the traveler and the places they visit. That’s why we’re deeply committed to sustainable and ethical tourism practices. This means:

Supporting local communities through employment and fair wages.
Minimizing our environmental impact through responsible waste management and conservation efforts.
Partnering with organizations that are working to protect wildlife and their habitats.
Educating our guests about the importance of conservation and responsible travel.

Client Testimonials and Success Stories

I always love reading what other people thought about a company before I try them out, so I wanted to include some real stories from Secret Africa’s clients. It’s one thing for a company to say they’re amazing, but it’s another thing entirely when their clients are raving about their experiences. These aren’t just generic reviews; they’re stories of incredible adventures and unforgettable moments. I think it’s important to share these, so you can get a feel for what a luxury African safari with Secret Africa is really like.

Unparalleled Local Knowledge

One of the things that really stood out to me was how many clients mentioned the guides’ knowledge. It wasn’t just about spotting animals; it was about understanding the ecosystem, the culture, and the history of the places they visited. Clients consistently praised the guides for going above and beyond, sharing insights that you just wouldn’t get from a guidebook.

“Our guide knew every bird call and animal track. It was like having a walking encyclopedia!”
“I learned so much about the local tribes and their traditions. It really enriched the whole experience.”
“The guides were passionate about conservation and shared their knowledge in a way that was both informative and inspiring.”

Luxury Tailored Experiences

Another recurring theme was the personalized service. Secret Africa doesn’t just offer cookie-cutter tours; they create bespoke itineraries that cater to each client’s individual interests and preferences. I think that’s a big deal, especially when you’re spending a lot of money on a trip. It’s nice to know that you’re getting something that’s truly tailored to you. The attention to detail really makes a difference.

“They took the time to understand what we wanted and created an itinerary that was perfect for us.”
“The accommodations were incredible, and the food was amazing. It felt like we were being pampered every step of the way.”
“They even arranged a surprise birthday celebration for my wife in the middle of the bush! It was unforgettable.”

Namibia

Namibia is seriously underrated, you guys. I mean, everyone goes on about South Africa and Botswana (which are amazing, don’t get me wrong), but Namibia? It’s got this raw, untouched beauty that just blows you away. Think massive sand dunes, crazy rock formations, and wildlife that’s adapted to some of the harshest conditions on earth. It’s a photographer’s dream, and honestly, just being there feels like you’re on another planet.

I’ve been doing some research, and Secret Africa seems to really get what makes a Namibian safari special. They don’t just take you to the usual tourist traps; they dig deeper and show you the real Namibia. Here’s what I’m hoping to experience:

Stargazing in the Namib Desert: Apparently, the night skies are so clear there that you can see the Milky Way in all its glory. I’m talking zero light pollution, just pure, unadulterated starlight. I’ve always wanted to see the Milky Way, so this is a big one for me.
Tracking desert-adapted elephants: These guys are incredible. They’ve learned to survive in the desert by finding underground water sources and traveling huge distances. Seeing them in their natural habitat would be unreal.
Exploring the Skeleton Coast: Okay, this sounds a bit morbid, but it’s actually fascinating. It’s a remote stretch of coastline littered with shipwrecks and whale bones. It’s eerie and beautiful at the same time, and it’s a reminder of just how powerful nature can be.

I’m also really interested in seeing the ancient rock art at Twyfelfontein and visiting the Himba people in the north. Namibia is just so diverse, and I feel like there’s so much to discover. I’m hoping Secret Africa can help me do just that.

Botswana

Botswana is a real gem, and Secret Africa knows how to show it off. It’s not just about seeing animals; it’s about experiencing the soul of Africa. I’m talking vast landscapes, incredible wildlife encounters, and a level of peace you just can’t find anywhere else. It’s a place that gets under your skin, in the best way possible.

Here’s what makes Botswana special with Secret Africa:

Unmatched Wildlife Viewing: Botswana is home to some of the largest elephant populations in Africa, plus lions, leopards, cheetahs, wild dogs, and countless bird species. The Okavango Delta is a must-see, offering a unique water-based safari experience.
Exclusive Camps and Lodges: Forget crowded tourist spots. Secret Africa partners with small, intimate camps that offer a truly private and luxurious experience. Think stunning views, gourmet meals, and personalized service.
Community Engagement: Secret Africa is committed to responsible tourism, working with local communities to ensure that your visit benefits the people and wildlife of Botswana. It’s about leaving a positive impact.

Booking Your Dream Safari with Secret Africa

So, you’re ready to book that amazing safari you’ve been dreaming about? Awesome! Secret Africa makes it pretty straightforward, and they’re super helpful every step of the way. I know planning a big trip like this can feel overwhelming, but trust me, it’s worth it.

Here’s a general idea of how it works:

Initial Consultation: It all starts with a chat. You’ll talk to one of their safari experts about what you’re looking for – what animals you want to see, what kind of accommodations you prefer (luxury lodge or something more rustic?), and your budget. This is where you really get to customize your trip. Don’t be shy about asking questions; they’ve heard it all before.
Itinerary Design: Based on your consultation, Secret Africa will put together a detailed itinerary just for you. This will include everything from flights and transfers to game drives and meals. They’ll usually give you a few options to choose from, so you can tweak things until it’s perfect.
Booking and Confirmation: Once you’re happy with the itinerary, it’s time to book! Secret Africa will handle all the reservations and paperwork. You’ll get a confirmation with all the important details, like flight times, hotel addresses, and emergency contact numbers.
Pre-Departure Support: In the weeks leading up to your trip, Secret Africa will be there to answer any last-minute questions and provide helpful tips. They can advise you on what to pack, what to expect, and how to stay safe. They really do think of everything!

Honestly, the best thing to do is just reach out to them. They’re really good at what they do, and they’ll make the whole process a breeze. Happy travels!

Ready to plan the safari of your dreams? At Secret Africa, we make it easy for you to explore the wild and experience nature like never before. Visit our website today to start your adventure and discover amazing packages that fit your needs!

Media Contact
Company Name: Secret Africa Safaris
Contact Person: Clyde Thomas
Email: Send Email
Phone: +27 21 204 6073
Address:Workshop 17, 17 Dock Road V&A Waterfront
City: Cape Town
State: Western Cape
Country: South Africa
Website: https://secretafrica.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Secret Africa: The Luxury Safari Company That Is Wowing Their Clients With Their Unique Local Knowledge

Host4Fun: Affordable High-Performance VPS Hosting Worldwide

“Experience unmatched speed and reliability with Host4Fun’s high-performance VPS Hosting. Powered by cutting-edge AMD Ryzen servers and lightning-fast NVMe storage, your applications run smoothly and respond instantly. Our Cloud VPS Hosting solution ensures ample bandwidth for heavy traffic and demanding tasks, allowing seamless scaling as your needs grow. Say goodbye to bottlenecks—Host4Fun elevates virtualization excellence!”

Host4Fun, a brand of QuadSpark IT Solutions Private Limited, provides VPS hosting services globally at reasonable prices. It has over ten years in the industry and offers both Linux and Windows VPS from various locations around the world. Recently, Host4Fun launched new VPS plans with AMD Ryzen 7950x processors, enhacing performance for gamers and Forex traders. The company promises excellent customer service along with fast, reliable, and high-quality hosting services.

Accelerate Your Online Growth with High-Performance VPS from Host4Fun.

Host4Fun, a brand of QuadSpark IT Solutions Private Limited, is offering high-performance Virtual Private Server (VPS) hosting solutions to support growing projects across the globe. With over 10 years of industry experience, Host4Fun provides reliable and affordable Linux VPS and Windows VPS hosting from diverse locations, including the USA, Europe, and Asia.

Designed to meet the evolving needs of businesses and individuals, Host4Fun’s VPS hosting plans are packed with powerful features and resources to ensure optimal performance and scalability. Whether you’re running a website, web application, e-commerce store, or any other online project, Host4Fun’s VPS solutions are engineered to handle your workload seamlessly.

“At Host4Fun, we understand that every project is unique, and that’s why we offer a range of VPS hosting plans to cater to different budgets and requirements,” said Riyad Siddique, co-founder of Host4Fun. “Our high-performance infrastructure, coupled with our commitment to exceptional customer service, makes Host4Fun the ideal choice for businesses and individuals seeking reliable and affordable VPS hosting solutions.”

Host4Fun’s VPS hosting plans are available in both Linux and Windows operating systems, providing users with the flexibility to choose the platform that best suits their needs. With data centers strategically located in the USA (New York City, Los Angeles, Miami, Dallas, Las Vegas, Seattle, San Jose, Chicago, Ashburn, Phoenix, North Carolina), Europe (Norway, Romania, UK, France, Poland, Germany & Finland), and Asia (Singapore), Host4Fun ensures low latency and fast page load times for users around the world.

Now, the company is taking its services to new heights by offering AMD Ryzen 7950x-powered packages, including Los Angeles VPS, VPS Finland, and Chicago VPS.

The AMD Ryzen is a cutting-edge processor that delivers unparalleled performance, making it the ideal choice for power-hungry applications, resource-intensive workloads, and demanding gaming environments. By integrating this state-of-the-art technology into its VPS offerings, QuadSpark is empowering its customers to unlock new levels of speed, efficiency, and productivity.

In addition to the new AMD Ryzen VPS plans, Host4Fun has also witnessed a surge in demand for its Singapore VPS plan, particularly among gamers from Asian countries. The company’s Singapore VPS offering is renowned for its low latency and high-speed connection, making it the preferred choice for gamers seeking a seamless and immersive gaming experience.

With over a decade of industry experience, Host4Fun has earned a reputation for delivering reliable, high-performance, and affordable virtual private server (VPS) hosting services to support growing projects across the globe. The company’s New York VPS hosting solutions are now the preferred choice for many Forex traders who rely on Meta Trading software to manage their trading activities.

Forex trading requires lightning-fast execution and rock-solid stability to maximize profits. Host4Fun’s New York VPS hosting solutions are engineered to deliver the performance, reliability, and low latency that Forex traders need to stay ahead of the market.

“We are committed to providing our clients with the best possible hosting experience,” added Gowtham Balaji, Director of QuadSpark IT Solutions Private Limited. “By offering budget-friendly VPS solutions across diverse locations without compromising on quality, we strive to make high-performance hosting accessible to businesses and individuals of all sizes.”

To learn more about Host4Fun’s VPS hosting solutions and to explore the available plans, please visit https://www.host4fun.com/.

About Host4Fun:

Host4Fun is a brand of QuadSpark IT Solutions Private Limited, a leading provider of reliable and affordable VPS hosting solutions. Established in 2014, Host4Fun has been serving businesses and individuals across the globe with its robust infrastructure and exceptional customer support.

For more information, please visit https://www.host4fun.com/.

Media Contact
Company Name: QuadSpark IT Solutions Private Limited
Contact Person: Riyad S
Email: Send Email
Phone: +919791580098
Address:5-2-2, Vangatasubbu Complex, Anjal Nagar 2nd Street
City: Madurai
State: Tamil Nadu
Country: India
Website: https://www.host4fun.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Host4Fun: Affordable High-Performance VPS Hosting Worldwide

Oncolytic Adenovirus Market Set to Grow Substantially Through 2032, DelveInsight Projects | CG Oncology, Orca Therapeutics B.V., Syneos Health, DNAtrix, Inc.

The Key Oncolytic Adenovirus Companies in the market include – CG Oncology, Inc., Orca Therapeutics B.V., Syneos Health, DNAtrix, Inc., and others.

The Oncolytic Adenovirus market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Oncolytic Adenovirus pipeline products will significantly revolutionize the Oncolytic Adenovirus market dynamics.

DelveInsight’s “Oncolytic Adenovirus Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Oncolytic Adenovirus, historical and forecasted epidemiology as well as the Oncolytic Adenovirus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Oncolytic Adenovirus market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Oncolytic Adenovirus market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Oncolytic Adenovirus Market Forecast

Some of the key facts of the Oncolytic Adenovirus Market Report:

The Oncolytic Adenovirus market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
In December 2024, TILT-123, an oncolytic adenovirus engineered with tumor necrosis factor alpha (TNFα) and interleukin-2 (IL-2), aims to improve the effectiveness of T-cell therapies such as immune checkpoint blockade and adoptive cell transfer. TILT’s strategy leverages oncolytic viruses to selectively replicate within and destroy cancer cells while also boosting immune responses against the tumor.
In April 2024, UK-based biotech firm Theolytics successfully raised £19 million ($24.5 million) in a funding round to support the advancement of its leading oncolytic adenovirus therapy, THEO-260.
Expected launch of promising therapies shall fuel the growth of the market during the forecast period, i.e., 2022–2032
Key Oncolytic Adenovirus Companies: CG Oncology, Inc., Orca Therapeutics B.V., Syneos Health, DNAtrix, Inc., and others
Key Oncolytic Adenovirus Therapies: CG0070, ORCA-010, OBP-301, DNX-2401, and others

Oncolytic Adenovirus Overview

Various forms of immunotherapy currently are emerging, including oncolytic viruses. In this therapy, viruses are engineered to selectively propagate in tumor cells and reduce toxicity for non-neoplastic tissues. Adenovirus is one of the most frequently employed oncolytic viruses because of its capacity in tumor cell lysis and immune response stimulation.

Oncolytic adenoviruses (OAds) are designed to replicate and induce oncolytic cell death selectively in tumor cells only by the deletion of a range of genes in the E1 region (55-kDagene in E1B, 24-bp gene in E1A, etc.) or driving the E1 gene expression through an integrated promoter (PSA, AFP, hTERT, etc.) that is activated in tumor cells.

Get a Free sample for the Oncolytic Adenovirus Market Report:

https://www.delveinsight.com/report-store/oncolytic-adenovirus-market

Oncolytic Adenovirus Epidemiology

Oncolytic Adenovirus Epidemiology Segmentation:

The Oncolytic Adenovirus market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Oncolytic Adenovirus
Prevalent Cases of Oncolytic Adenovirus by severity
Gender-specific Prevalence of Oncolytic Adenovirus
Diagnosed Cases of Episodic and Chronic Oncolytic Adenovirus

Download the report to understand which factors are driving Oncolytic Adenovirus epidemiology trends @ Oncolytic Adenovirus Epidemiological Insights

Oncolytic Adenovirus Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Oncolytic Adenovirus market or expected to get launched during the study period. The analysis covers Oncolytic Adenovirus market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report also covers the Oncolytic Adenovirus Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Oncolytic Adenovirus Therapies and Key Companies

CG0070: CG Oncology, Inc.
ORCA-010: Orca Therapeutics B.V.
OBP-301: Syneos Health
DNX-2401: DNAtrix, Inc

To know more about Oncolytic Adenovirus treatment, visit @ Oncolytic Adenovirus Medications

Oncolytic Adenovirus Market Drivers

Advancements in Gene Therapy
Rising Cancer Incidence
FDA and Regulatory Support
Combination Therapy Potential
Growing Investments and Collaborations
Personalized Medicine Approach
Technological Advancements in Viral Vector Production

Oncolytic Adenovirus Market Barriers

High Development Costs
Regulatory Challenges
Limited Clinical Data
Immune System Response
Manufacturing Complexities
Reimbursement and Pricing Issues
Competition from Other Oncolytic Viruses

Scope of the Oncolytic Adenovirus Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Oncolytic Adenovirus Companies: CG Oncology, Inc., Orca Therapeutics B.V., Syneos Health, DNAtrix, Inc., and others
Key Oncolytic Adenovirus Therapies: CG0070, ORCA-010, OBP-301, DNX-2401, and others
Oncolytic Adenovirus Therapeutic Assessment: Oncolytic Adenovirus current marketed and Oncolytic Adenovirus emerging therapies
Oncolytic Adenovirus Market Dynamics: Oncolytic Adenovirus market drivers and Oncolytic Adenovirus market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Oncolytic Adenovirus Unmet Needs, KOL’s views, Analyst’s views, Oncolytic Adenovirus Market Access and Reimbursement

Discover more about therapies set to grab major Oncolytic Adenovirus market share @ Oncolytic Adenovirus Treatment Landscape

Table of Contents

1. Oncolytic Adenovirus Market Report Introduction

2. Executive Summary for Oncolytic Adenovirus

3. SWOT analysis of Oncolytic Adenovirus

4. Oncolytic Adenovirus Patient Share (%) Overview at a Glance

5. Oncolytic Adenovirus Market Overview at a Glance

6. Oncolytic Adenovirus Disease Background and Overview

7. Oncolytic Adenovirus Epidemiology and Patient Population

8. Country-Specific Patient Population of Oncolytic Adenovirus

9. Oncolytic Adenovirus Current Treatment and Medical Practices

10. Oncolytic Adenovirus Unmet Needs

11. Oncolytic Adenovirus Emerging Therapies

12. Oncolytic Adenovirus Market Outlook

13. Country-Wise Oncolytic Adenovirus Market Analysis (2019–2032)

14. Oncolytic Adenovirus Market Access and Reimbursement of Therapies

15. Oncolytic Adenovirus Market Drivers

16. Oncolytic Adenovirus Market Barriers

17. Oncolytic Adenovirus Appendix

18. Oncolytic Adenovirus Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Oncolytic Adenovirus Market Set to Grow Substantially Through 2032, DelveInsight Projects | CG Oncology, Orca Therapeutics B.V., Syneos Health, DNAtrix, Inc.

The NF1-PN Market in 7MM to Witness Notable Growth, Expanding from USD 380 million in 2023 | DelveInsight

The ongoing NF1-PN drug development pipeline features additional MEK inhibitors, including Mirdametinib (SpringWorks Therapeutics), FCN-159 (Fosun Pharmaceutical), and PAS-004 (Pasithea Therapeutics). Additionally, HLX-1502 (Healx) is an emerging investigational therapy that provides a novel treatment approach for NF1 patients.

The Neurofibromatosis type 1-associated Plexiform Neurofibromas market across the 7MM is expected to surge owing to an increased awareness, advancements in diagnostic techniques, greater accessibility to genetic testing, and the emergence of new transformative treatments such as KOSELUGO (AstraZeneca and Merck), Mirdametinib (SpringWorks Therapeutics), HLX-1502 (Healx), FCN-159 (Fosun Pharmaceutical), and AS-004 (Pasithea Therapeutics).

DelveInsight’s report titled “Neurofibromatosis Type 1-associated Plexiform Neurofibromas (NF1-PN): Market Insights, Epidemiology, and Market Forecast – 2034” offers comprehensive epidemiological data along with insights into market trends, an analysis of the competitive landscape, current and emerging therapeutic approaches, and assessments of the patient journey concerning NF1-PN, a rare disease.

The report forecasts that the NF1-PN market across the 7MM, which includes the United States, the EU4 countries (Germany, France, Italy, and Spain), the United Kingdom, and Japan, will grow from ~USD 380 million in 2023 at a considerable CAGR by 2034. This anticipated growth is attributed to ongoing research into the genetic underpinnings of these tumors, the availability of medical therapy as an alternative to surgery, improvements in administration ease, and a decrease in side effect profiles of emerging therapies.

According to the report, the United States consistently holds the highest market share among the 7MM, with around USD 230 million in 2023.

The report provides a detailed epidemiological analysis and forecasts up to 2034, segmented by total NF1 diagnosed prevalent cases, diagnosed cases of NF1 manifestations, age-specific NF1-PN diagnosed cases, NF1-PN cases by clinical symptoms, and NF1-PN cases eligible for surgery in the 7MM. In 2023, the majority of diagnosed NF1-PN patients were estimated to be in the US, followed by Germany.

Current NF1-PN treatment practices, emerging drugs, market shares of individual therapies, and unmet medical needs from 2020 to 2034 are also addressed in the report. While surgery remains a standard treatment for many patients, it is often complex, not always feasible, carries inherent risks, and has a high possibility of tumor recurrence. A multidisciplinary approach involving genetics, neurology, radiology, and surgery, is vital for effectively managing the disease’s physical and emotional impacts.

With an improved understanding of the genetic basis of plexiform neurofibromas, targeted therapies like the MEK inhibitor KOSELUGO (AstraZeneca and Merck) have emerged as promising options, especially for pediatric patients with inoperable NF1-PN. Building on this progress, researchers are exploring other MEK inhibitors for potential use in both pediatric and adult patients.

The current NF1-PN developmental pipeline includes additional MEK inhibitors such as Mirdametinib (SpringWorks Therapeutics), FCN-159 (Fosun Pharmaceutical), and PAS-004 (Pasithea Therapeutics). Another emerging drug, HLX-1502 (Healx), offers a unique investigational treatment option for NF1 patients. In October 2024, the US FDA granted Fast Track Designation (FTD) to HLX-1502 for the treatment of NF1.

Recent developments include findings for PAS-004, which demonstrated no dose-limiting toxicities in Phase 1 clinical trials. An external Safety Review Committee recommended proceeding with its higher doses without modification in February 2025, highlighting the potential of these emerging therapies to revolutionize NF1-PN treatment.

Although NF1-PN presents significant challenges due to its highly individualized treatment needs—including multidisciplinary teamwork, tumor regrowth, and complications arising from tumors developing in critical areas like the head, neck, chest, or spine—the emergence of novel therapies as an alternative to surgery, improving administration ease and minimize side effects, is expected to broaden treatment options and enhance market growth.

Table of Contents

1.	KEY INSIGHTS
2.	REPORT INTRODUCTION
3.	EXECUTIVE SUMMARY OF NF1-PN
4.	EPIDEMIOLOGY AND MARKET METHODOLOGY
5.	NF1-PN MARKET OVERVIEW AT A GLANCE
6.	KEY EVENTS
7.	DISEASE BACKGROUND AND OVERVIEW
8.	EPIDEMIOLOGY AND PATIENT POPULATION
9.	PATIENT JOURNEY
10.	MARKETED DRUGS
11.	EMERGING DRUGS
12.	NF1-PN: SEVEN MAJOR MARKET ANALYSIS
13.	UNMET NEEDS
14.	SWOT ANALYSIS
15.	KOL VIEWS
16.	MARKET ACCESS AND REIMBURSEMENT
17.	APPENDIX
18.	DELVEINSIGHT CAPABILITIES
19.	DISCLAIMER
20.	ABOUT DELVEINSIGHT

Plexiform neurofibroma Pipeline Insight provides comprehensive insights about the Plexiform neurofibroma pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the Plexiform neurofibroma companies, including SpringWorks Therapeutics, Array BioPharma, Novartis, Shanghai Fosun Pharmaceutical Development Co, Ltd.,and Ashvattha Therapeutics, among others.

Plexiform Neurofibroma Market Insight

Plexiform Neurofibroma Market Insight, Epidemiology And Market Forecast report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Plexiform Neurofibroma market trends, market drivers, market barriers, and key Plexiform Neurofibroma companies, including SpringWorks Therapeutics, Array BioPharma, Novartis, Shanghai Fosun Pharmaceutical Development Co, Ltd.,and Ashvattha Therapeutics, among others.

About DelveInsight

DelveInsight is a leading business Healthcare consultancy and market research firm specializing in life sciences. It assists pharmaceutical companies by offering comprehensive, end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The NF1-PN Market in 7MM to Witness Notable Growth, Expanding from USD 380 million in 2023 | DelveInsight

Dave Miles Starts 2025 With Two Singles

Canadian Native Dave Miles Transitions from the Ice to Ignite the Blues Rock Scene with His Eclectic Sound

Canadian singer-songwriter Dave Miles is kicking off 2025 with a powerful one-two punch of new music that underscores his signature storytelling style. We are excited to share the release of his second single of the year, Dichotomy, a vibrant, genre-bending track that explores the complex dualities of human nature. This follows the launch of Dead A Long Time, which debuted earlier this year on January 3. These singles follow up on the launch of Dave’s career in 2024 with the release of his debut studio single, Silver Lake.

Dichotomy showcases Miles’ knack for crafting vivid, relatable narratives with a dose of wit. The song paints a portrait of an unpredictable, charismatic character who embodies contradiction at every turn. Lines like “She’ll wash your clothes, toss them in the street” and “Meet your folks charming as can be, at home she’ll slap your face” highlight Miles’ ability to mix humor and introspection in a way that feels fresh and genuine. Dead A Long Time celebrates the fast-paced life of a sales dealmaker who lives by the mantra, “Life is short, you’re dead a long time.” The track is sure to resonate with anyone striving to make the most of their time, balancing ambition and self-reflection.

Both singles are produced by EMAC Studios alongside Moe Berg, maintaining the rich, textured sound that has become synonymous with Miles’s work. Together, they set the stage for a groundbreaking year as he continues to evolve as an artist and connect with fans through authentic and compelling music. Listen to these new singles today on all digital streaming platforms and experience the journey of contrasts and connections only Dave Miles can deliver.

Get ready to dive into Dave Miles’ enchanting world of Blues Rock by exploring his latest works and connecting with his ongoing journey. Visit his Spotify to discover the music that fans and musicians are already buzzing about.

ABOUT

Originally hailing from Canada, Dave Miles is a former professional hockey player who once skated with the Detroit Red Wings organization, playing for teams like Kalamazoo and several other minor league affiliates. Transitioning from the rink to the boardroom, Dave later carved out a successful career as a senior executive in the hospitality and service industry. He currently resides in Clearwater, FL, with his two children, Mackenzie and Jack. Dave’s foray into music began six years ago, spurred by a request from a former teammate. This teammate, recalling Dave’s vocal talents from their jamming sessions during their hockey days, asked him to lend his voice to a song written in honor of his father, Stormin Norman, a highly decorated WWII hero. Despite not playing an instrument, Dave has found a supportive team at EMAC Studios in London to help bring his musical visions to life. Among his favorite works are “Silver Lake,” a song that evokes the cherished memories of his family’s cottage, owned since 1939, and “Mimosa Sunday’s,” a track that quickly gained favor with his producer and session players for its catchy and engaging vibe.

LINKS

https://www.youtube.com/channel/UCchm3mMaCCZhd2-xt10tILA

https://www.facebook.com/profile.php?id=61559948373077

https://www.instagram.com/davemiles17

https://www.tiktok.com/@david.miles45

Media Contact
Company Name: Edward Scheindlin
Email: Send Email
Phone: 800-983-1362
City: Clearwater
State: Florida
Country: United States
Website: https://www.youtube.com/channel/UCchm3mMaCCZhd2-xt10tILA

Maasai Mara’s Legendary Lion Lorkulup Honored On New York Times Square

WanMiaoYiWang Pet Service Company and Chinese Wildlife Enthusiasts Call for Global Attention to the Survival Crisis of African Lions

On March 3, 2025 (New York time), Nanjing WanMiaoYiWang Pet Services Co., Ltd., in collaboration with nearly 200 Chinese wildlife conservationists, hosted a special event in Times Square, New York, to honor one of the most legendary lions—Lorkulup, a member of the Black Rock Boys. The event featured an immersive video exhibition and the distribution of informational brochures to raise awareness about the immense challenges facing African lions.

At the event, a memorial video created by Chinese lion enthusiasts was played on the LED screen at the 41st Street in Times Square. The video vividly showcased Lorkulup’s majestic presence on the African savanna, expressing the deep remembrance of his admirers. Additionally, posters and flyers featuring heart-touching images drew the attention of passersby.

A tourist, Mr. Peris, commented:“This event is very meaningful. I had never realized how challenging the survival environment for African wildlife is. From now on, I will pay more attention to them and contribute to wildlife conservation.”

Lion fans were there to support the event and share information about Maasai Mara’s wild lions and other wildlife challenges with pedestrians.

Ms. Yingxi, one of the attendees, shared:“My boyfriend and I happened to be in New York during this event, and we feel honored to speak up for Lorkulup and other wild animals. Lorkulup’s tragic passing was heartbreaking for many lion enthusiasts, and will learn about the Maasai Mara lions—they need our help.”

The Maasai Mara National Reserve is Kenya’s most renowned wildlife sanctuary, famous for its Great Migration and the “Big Five.” Lions, in particular, are key species in the ecosystem and major attractions for tourists worldwide. Many lions in the region receive officially recognized names, and Lorkulup was one of them.

As one of the most influential lion kings in recent years, Lorkulup was admired for his exceptional hunting skills and gentle, family-oriented nature. Visitors traveled from all over the world just to catch a glimpse of him. However, despite being in his prime at 7.5 years old, he was tragically found dead on January 25, 2025.

Lorkulup(2017.8-2025.1) photo by Vipul Khatri

Notably, exactly one year and one day earlier, on January 24, 2024, another famous lion from the Black Rock Boys coalition, Olobor, died due to human-wildlife conflict. Then, just a few weeks after Lorkulup’s passing, on February 6, 2025, a more severe incident occurred at the border of Maasai Mara and Serengeti.

In retaliation for a livestock attack by lion king Osopia and a sub-group of the Oloolaimutia pride, which killed a cow on February 1, local herders poisoned five lions and over 13 hyenas.

These consecutive deaths of iconic lions highlight the serious survival crisis of African lions, calling for an urgent reassessment of human-wildlife relationships.

0lobor(2017.8-2024.1) photo by Elmoundo Wild

While Maasai Mara is a top wildlife tourism destination, its booming industry has led to habitat fragmentation due to the expansion of tourism facilities, shrinking territories for animals. Additionally, some irresponsible tourist behaviors, such as chasing or feeding wild animals, further intensify ecological pressures.

However, the greatest threat to African lions remains human-wildlife conflict—particularly conflicts with the local Maasai herders and illegal grazing activities. In recent years, over 50 documented lions, 6 leopards, and 15 cheetahs have reportedly died due to human-wildlife clashes in the Maasai Mara region. The actual number of unrecorded deaths remains unknown.

Mr. Chen, the event organizer, emphasized:“This event is not just about remembering Lorkulup but also a global call to action. We want people everywhere to recognize the importance of wildlife conservation.”

This Times Square event marks the second major tribute to Lorkulup, following the first memorial held in London’s Westfield on February 15, 2025.

Media Contact
Company Name: WanMiaoYiWang Pet Service Company
Contact Person: Bingqian Xue
Email: Send Email
City: Nanjing
Country: China
Website: http://www.wanmiaoyiwang.com/